van Oostrom JC - Search Results

1

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo.

Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH. Kortekaas R, et al. Among authors: van oostrom jc. Ann Neurol. 2005 Feb;57(2):176-9. doi: 10.1002/ana.20369. Ann Neurol. 2005. PMID: 15668963

2

Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.

Bartels AL, Willemsen AT, Kortekaas R, de Jong BM, de Vries R, de Klerk O, van Oostrom JC, Portman A, Leenders KL. Bartels AL, et al. Among authors: van oostrom jc. J Neural Transm (Vienna). 2008 Jul;115(7):1001-9. doi: 10.1007/s00702-008-0030-y. Epub 2008 Feb 12. J Neural Transm (Vienna). 2008. PMID: 18265929 Free PMC article.

3

Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration.

Bartels AL, Kortekaas R, Bart J, Willemsen AT, de Klerk OL, de Vries JJ, van Oostrom JC, Leenders KL. Bartels AL, et al. Among authors: van oostrom jc. Neurobiol Aging. 2009 Nov;30(11):1818-24. doi: 10.1016/j.neurobiolaging.2008.02.002. Epub 2008 Mar 20. Neurobiol Aging. 2009. PMID: 18358568

4

Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease.

van Oostrom JC, Maguire RP, Verschuuren-Bemelmans CC, Veenma-van der Duin L, Pruim J, Roos RA, Leenders KL. van Oostrom JC, et al. Neurology. 2005 Sep 27;65(6):941-3. doi: 10.1212/01.wnl.0000176071.08694.cc. Neurology. 2005. PMID: 16186542

5

Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's disease.

van Oostrom JC, Dekker M, Willemsen AT, de Jong BM, Roos RA, Leenders KL. van Oostrom JC, et al. Eur J Neurol. 2009 Feb;16(2):226-31. doi: 10.1111/j.1468-1331.2008.02390.x. Epub 2008 Dec 9. Eur J Neurol. 2009. PMID: 19138335

6

Typical cerebral metabolic patterns in neurodegenerative brain diseases.

Teune LK, Bartels AL, de Jong BM, Willemsen AT, Eshuis SA, de Vries JJ, van Oostrom JC, Leenders KL. Teune LK, et al. Among authors: van oostrom jc. Mov Disord. 2010 Oct 30;25(14):2395-404. doi: 10.1002/mds.23291. Mov Disord. 2010. PMID: 20669302

7

Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease.

Herben-Dekker M, van Oostrom JC, Roos RA, Jurgens CK, Witjes-Ané MN, Kremer HP, Leenders KL, Spikman JM. Herben-Dekker M, et al. Among authors: van oostrom jc. J Neurol. 2014 Jul;261(7):1387-97. doi: 10.1007/s00415-014-7350-7. Epub 2014 Apr 30. J Neurol. 2014. PMID: 24781835

8

1H magnetic resonance spectroscopy in preclinical Huntington disease.

van Oostrom JC, Sijens PE, Roos RA, Leenders KL. van Oostrom JC, et al. Brain Res. 2007 Sep 7;1168:67-71. doi: 10.1016/j.brainres.2007.05.082. Epub 2007 Jul 17. Brain Res. 2007. PMID: 17707354

9

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.

Moss DJH, Pardiñas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S; TRACK-HD investigators; REGISTRY investigators; Holmans P, Jones L, Tabrizi SJ. Moss DJH, et al. Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20. Lancet Neurol. 2017. PMID: 28642124

10

Metabolic network as a progression biomarker of premanifest Huntington's disease.

Tang CC, Feigin A, Ma Y, Habeck C, Paulsen JS, Leenders KL, Teune LK, van Oostrom JC, Guttman M, Dhawan V, Eidelberg D. Tang CC, et al. Among authors: van oostrom jc. J Clin Invest. 2013 Sep;123(9):4076-88. doi: 10.1172/JCI69411. Epub 2013 Aug 29. J Clin Invest. 2013. PMID: 23985564 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page